Patients who received lovo-cel had durable remissions and reductions in vaso-occlusive events, pain crises, and hospitalizations in the longest running gene therapy trial for sickle cell disease.
Lower risk of bacteremia in children with sickle cell disease (SCD) presenting to the emergency department (ED) with fever calls critical reexamination of long standing approach towards management of SCD in children.